2 Works

Long-term response to sintilimab, bevacizumab and chemotherapy in heavily pretreated microsatellite stable colon cancer. Supplementary Figure.

Quanli Han, Beifang Niu, Sheng Liu, Erhong Meng, Muhong Deng, Qi Wang & Zhi Cui
Figure published via Future Science Group
Supplmentary figure 1
No citations were reported. No usage information was reported.
https://doi.org/10.25402/imt.21988496 Cite

Long-term response to sintilimab, bevacizumab and chemotherapy in heavily pretreated microsatellite stable colon cancer. Supplementary Figure.

Quanli Han, Beifang Niu, Sheng Liu, Erhong Meng, Muhong Deng, Qi Wang & Zhi Cui
Figure published via Future Science Group
Supplmentary figure 1
No citations were reported. No usage information was reported.
https://doi.org/10.25402/imt.21988496.v1 Cite

Registration Year

  • 2023
    2

Resource Types

  • Image
    2

Affiliations

  • State Administration of Traditional Chinese Medicine of the People's Republic of China
    2
  • West China Hospital of Sichuan University
    2
  • Zhejiang University
    2
  • Central South University
    2
  • Jilin University
    2
  • Air Force Medical University
    2
  • Huazhong University of Science and Technology
    2
  • Anhui University of Science and Technology
    2
  • Shanghai University of Traditional Chinese Medicine
    2
  • Sichuan University
    2

About DataCite

Services

Resources

Community